LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 27.84 | 770.25 | 1158 | 2833 | 0.4086 | 0.2423 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 30.06 | 770.25 | 1341 | 3106 | 0.4317 | 0.3173 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 30.06 | 770.25 | 1143 | 3106 | 0.3680 | 0.2168 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 32.28 | 770.25 | 1265 | 3392 | 0.3728 | 0.2610 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 32.28 | 770.25 | 1154 | 3392 | 0.3401 | 0.2080 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 34.50 | 770.25 | 1369 | 3712 | 0.3688 | 0.2885 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 34.50 | 770.25 | 1171 | 3712 | 0.3155 | 0.2028 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 36.73 | 770.25 | 1376 | 4086 | 0.3368 | 0.2726 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 36.73 | 770.25 | 1167 | 4086 | 0.2856 | 0.1884 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 38.95 | 770.25 | 1362 | 4543 | 0.2997 | 0.2493 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 38.95 | 770.25 | 1177 | 4543 | 0.2590 | 0.1801 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 41.17 | 770.25 | 1351 | 5010 | 0.2696 | 0.2312 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 41.17 | 770.25 | 1168 | 5010 | 0.2331 | 0.1666 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 43.39 | 770.25 | 1377 | 5404 | 0.2548 | 0.2296 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 43.39 | 770.25 | 1191 | 5404 | 0.2204 | 0.1677 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 45.61 | 770.25 | 1368 | 5813 | 0.2353 | 0.2177 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 45.61 | 770.25 | 1179 | 5813 | 0.2028 | 0.1572 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 47.83 | 770.25 | 1381 | 6223 | 0.2219 | 0.2137 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 47.83 | 770.25 | 1225 | 6223 | 0.1968 | 0.1664 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 50.05 | 770.25 | 1380 | 6629 | 0.2082 | 0.2066 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 50.05 | 770.25 | 1211 | 6629 | 0.1827 | 0.1569 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 52.27 | 770.25 | 1371 | 7058 | 0.1942 | 0.1977 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 52.27 | 770.25 | 1187 | 7058 | 0.1682 | 0.1449 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 54.49 | 770.25 | 1362 | 7555 | 0.1803 | 0.1889 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 54.49 | 770.25 | 1244 | 7555 | 0.1647 | 0.1567 | MN20160304_L02 | G17 |